{"id":537227,"date":"2018-10-21T06:12:02","date_gmt":"2018-10-21T10:12:02","guid":{"rendered":"http:\/\/spaceweekly.com\/?guid=830d12e56f67011252dc6f3aaec8fbb3"},"modified":"2018-10-21T06:12:02","modified_gmt":"2018-10-21T10:12:02","slug":"roche-takes-on-loxo-bayer-in-gene-defined-cancer-class","status":"publish","type":"post","link":"https:\/\/spaceweekly.com\/?p=537227","title":{"rendered":"Roche takes on Loxo, Bayer in gene-defined cancer class"},"content":{"rendered":"<p>Roche&#8217;s entrectinib cancer pill was shown to shrink tumors in 57 percent of patients within a group that can only be identified via genetic profiling, as the Swiss drugmaker challenges an alliance of Bayer and Loxo Oncology in a new targeted treatment area.<\/p>\n<div class=\"feedflare\">\n<a href=\"http:\/\/feeds.reuters.com\/~ff\/reuters\/scienceNews?a=Ol4huMEpOio:oeoATSFk6PQ:yIl2AUoC8zA\"><img decoding=\"async\" src=\"http:\/\/feeds.feedburner.com\/~ff\/reuters\/scienceNews?d=yIl2AUoC8zA\" border=\"0\"><\/img><\/a> <a href=\"http:\/\/feeds.reuters.com\/~ff\/reuters\/scienceNews?a=Ol4huMEpOio:oeoATSFk6PQ:F7zBnMyn0Lo\"><img decoding=\"async\" src=\"http:\/\/feeds.feedburner.com\/~ff\/reuters\/scienceNews?i=Ol4huMEpOio:oeoATSFk6PQ:F7zBnMyn0Lo\" border=\"0\"><\/img><\/a> <a href=\"http:\/\/feeds.reuters.com\/~ff\/reuters\/scienceNews?a=Ol4huMEpOio:oeoATSFk6PQ:V_sGLiPBpWU\"><img decoding=\"async\" src=\"http:\/\/feeds.feedburner.com\/~ff\/reuters\/scienceNews?i=Ol4huMEpOio:oeoATSFk6PQ:V_sGLiPBpWU\" border=\"0\"><\/img><\/a>\n<\/div>\n<p><img loading=\"lazy\" decoding=\"async\" src=\"http:\/\/feeds.feedburner.com\/~r\/reuters\/scienceNews\/~4\/Ol4huMEpOio\" height=\"1\" width=\"1\" alt=\"\"\/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Roche&#8217;s entrectinib cancer pill was shown to shrink tumors in 57 percent of patients within a group that can only be identified via genetic profiling, as the Swiss drugmaker challenges an alliance of Bayer and Loxo Oncology in a new targeted treatment &#8230;<\/p>\n","protected":false},"author":76,"featured_media":615444,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-537227","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry"],"_links":{"self":[{"href":"https:\/\/spaceweekly.com\/index.php?rest_route=\/wp\/v2\/posts\/537227","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/spaceweekly.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/spaceweekly.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/spaceweekly.com\/index.php?rest_route=\/wp\/v2\/users\/76"}],"replies":[{"embeddable":true,"href":"https:\/\/spaceweekly.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=537227"}],"version-history":[{"count":1,"href":"https:\/\/spaceweekly.com\/index.php?rest_route=\/wp\/v2\/posts\/537227\/revisions"}],"predecessor-version":[{"id":537228,"href":"https:\/\/spaceweekly.com\/index.php?rest_route=\/wp\/v2\/posts\/537227\/revisions\/537228"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/spaceweekly.com\/index.php?rest_route=\/wp\/v2\/media\/615444"}],"wp:attachment":[{"href":"https:\/\/spaceweekly.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=537227"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/spaceweekly.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=537227"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/spaceweekly.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=537227"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}